Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Outcubation—where incubation meets outsourcing

Subjects

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Pros and cons of the different approaches for externalization of R&D efforts in the pharmaceutical industry.

References

  1. Anonymous. Nat. Biotechnol. 32, 109 (2014).

  2. Schuhmacher, A. et al. Drug Discov. Today 18, 1133–1137 (2013).

    Article  Google Scholar 

  3. Chesbrough, H.W. Open Innovation: The New Imperative for Creating and Profiting from Technology (Harvard Business School Press, 2003).

    Google Scholar 

  4. Getz, K. & Kaitin, K. Expert Rev. Clin. Pharmacol. 5, 481–483 (2012).

    Article  CAS  Google Scholar 

  5. Hunter, J. & Stephens, S. Nat. Rev. Drug Discov. 9, 87–88 (2010).

    Article  CAS  Google Scholar 

  6. Comanor, W. et al. J. Health Econ. 32, 106–113 (2013).

    Article  Google Scholar 

  7. Stokes, D. Pasteur's Quadrant: Basic Science and Technological Innovation (Brookings Institution Press, 1997).

    Google Scholar 

  8. Dugan, R. & Gabriel, K. Harvard Business Review, (October 2013) https://hbr.org/2013/10/special-forces-innovation-how-darpa-attacks-problems.

  9. Emmert-Buck, M. J. Transl. Med. 9, 54–57 (2011).

    Article  Google Scholar 

Download references

Acknowledgements

We thank F. Rippmann, M. Wolf and R. Lindemann for their engagement as industry project champions; R. Wade, M. Patil and V. Umansky for their engagement as academic mentors; A. Miranville, G. Hirschel, O. Bauer, S. Heitz and G. Ries for their contributions in contracting this new model; and A. Wiest, B. Kirschbaum, K. Urbahns, S. Arkinstall, C. Huber and J. Schwiezer for their contributions in the Joint Steering Committee.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ulrich A K Betz.

Ethics declarations

Competing interests

Christian Tidona is the CEO of BioMed X GmbH and Ulrich Betz works for Merck KGaA as Head of Innovation, Merck Serono.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Betz, U., Tidona, C. Outcubation—where incubation meets outsourcing. Nat Biotechnol 33, 20–21 (2015). https://doi.org/10.1038/nbt.3112

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3112

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research